|
TMEM188 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09288142372088E-12 |
| Normal-vs-Stage2 |
3.53330000002483E-06 |
| Normal-vs-Stage3 |
2.23689999999666E-05 |
| Normal-vs-Stage4 |
1.294770E-01 |
| Stage1-vs-Stage2 |
1.272350E-01 |
| Stage1-vs-Stage3 |
5.030000E-01 |
| Stage1-vs-Stage4 |
5.384800E-01 |
| Stage2-vs-Stage3 |
4.366800E-01 |
| Stage2-vs-Stage4 |
1.617360E-01 |
| Stage3-vs-Stage4 |
3.873600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.71440000044043E-07 |
| Normal-vs-Asian |
4.329900E-02 |
| Caucasian-vs-AfricanAmerican |
3.745400E-01 |
| Caucasian-vs-Asian |
2.469800E-01 |
| AfricanAmerican-vs-Asian |
1.906350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
4.59030002897265E-09 |
| Male-vs-Female |
9.941400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.184000E-04 |
| Normal-vs-Extreme_Weight |
2.90334423169725E-12 |
| Normal-vs-Obese |
6.51480003277527E-09 |
| Normal-vs-Extreme_Obese |
9.401100E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.707700E-02 |
| Normal_Weight-vs-Obese |
1.214170E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.146000E-01 |
| Extreme_Weight-vs-Obese |
8.716200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.639000E-01 |
| Obese-vs-Extreme_Obese |
9.442000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.584500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.71063163634244E-12 |
| Normal-vs-Age(81-100Yrs) |
1.452450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.250600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.013400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.955000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.114400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.792200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.308800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
8.50760000004058E-07 |
| Normal-VS-KIRP CIMP |
3.744000E-03 |
| Normal-VS-Unclassified PRCC |
1.75539999980323E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.862290E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.880200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.997250E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.479200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.521400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.428000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.50240000007918E-07 |
| Normal-vs-N1 |
7.63209999999903E-05 |
| Normal-vs-N2 |
5.118600E-01 |
| N0-vs-N1 |
6.984800E-01 |
| N0-vs-N2 |
3.099400E-01 |
| N1-vs-N2 |
2.191600E-01 |
|
|
